These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3338 related articles for article (PubMed ID: 32398132)
41. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer. Cheng Y; Wang M; Zhou J; Dong H; Wang S; Xu H Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808751 [TBL] [Abstract][Full Text] [Related]
42. Epigenetic Methylations on N6-Adenine and N6-Adenosine with the same Input but Different Output. Li Z; Zhao P; Xia Q Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208067 [TBL] [Abstract][Full Text] [Related]
43. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Zhang B; Jiang H; Dong Z; Sun A; Ge J Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705 [TBL] [Abstract][Full Text] [Related]
44. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Chen M; Wong CM Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216 [TBL] [Abstract][Full Text] [Related]
45. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related]
46. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320 [TBL] [Abstract][Full Text] [Related]
47. Interaction between N Chen Y; Lin Y; Shu Y; He J; Gao W Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966 [TBL] [Abstract][Full Text] [Related]
48. Aberrant Regulation of mRNA m⁶A Modification in Cancer Development. Luo J; Liu H; Luan S; He C; Li Z Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149601 [No Abstract] [Full Text] [Related]
49. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions. Imam H; Kim GW; Siddiqui A Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128 [TBL] [Abstract][Full Text] [Related]
50. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
51. Association of N6-methyladenosine with viruses and related diseases. Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514 [TBL] [Abstract][Full Text] [Related]
52. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma. Fu Y; Sun S; Bi J; Kong C; Yin L Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886 [TBL] [Abstract][Full Text] [Related]
53. Functions of RNA N6-methyladenosine modification in cancer progression. Chen B; Li Y; Song R; Xue C; Xu F Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972 [TBL] [Abstract][Full Text] [Related]
54. Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration. Shu L; Huang X; Cheng X; Li X Cells; 2021 Oct; 10(10):. PubMed ID: 34685675 [TBL] [Abstract][Full Text] [Related]
55. Roles of RNA methylation by means of N Wang S; Sun C; Li J; Zhang E; Ma Z; Xu W; Li H; Qiu M; Xu Y; Xia W; Xu L; Yin R Cancer Lett; 2017 Nov; 408():112-120. PubMed ID: 28867248 [TBL] [Abstract][Full Text] [Related]
56. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. Ma H; Shen L; Yang H; Gong H; Du X; Li J IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540 [TBL] [Abstract][Full Text] [Related]
57. Functions of RNA N6-methyladenosine modification in cancer progression. Chen B; Li Y; Song R; Xue C; Xu F Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764 [TBL] [Abstract][Full Text] [Related]
58. N6-methyladenosine links RNA metabolism to cancer progression. Dai D; Wang H; Zhu L; Jin H; Wang X Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143 [TBL] [Abstract][Full Text] [Related]
59. The interplay between m6A RNA methylation and noncoding RNA in cancer. Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221 [TBL] [Abstract][Full Text] [Related]
60. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. Petri BJ; Klinge CM J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]